Director/PDMR Shareholding

22 July 2011

Synergy Health plc ("Synergy" or the "Company")

Director/PDMR Shareholding

The company has been informed that on 19 July 2011 Adrian Coward, CEO UK and Ireland, exercised options granted under the Synergy Health Executive Share Option Scheme over 488 shares at 405.5 pence and 2059 shares at 430 pence. Of these shares 1,547 were sold on that day at a price of 933.464 pence. He has retained 1,000 shares and has allocated these shares to the LTIP Co-Invest scheme. As such, Adrian Coward has been awarded 2,000 LTIP Co-Invest options. Following this transaction, Mr Coward has an interest in 6,059 Ordinary Shares, representing 0.011 % of the Company's issued share capital.

The LTIP Co-Invest arrangement requires that the participant to whom the award is to be made invests in Ordinary Shares in the Company and continues to hold those Ordinary Shares throughout the three year measurement period. At the end of the measurement period, depending upon the growth in earnings per share of the Company over the measurement period, the participant will receive a number of "matching" shares at nominal value under the LTIP Co-Invest.

Enquiries

Tim Mason

Company Secretary

01793 891862